BioNTech Announces Second Quarter 2025 Financial Results and Corporate Update
Continued execution of BioNTech’s oncology strategy with focus on two pan-tumor programs…
Apogee Therapeutics to Host Conference Call to Report Part A 16-Week Data from the Phase 2 APEX Trial of APG777 in Patients with Moderate-to-Severe Atopic Dermatitis on July 7, 2025
SAN FRANCISCO and BOSTON, July 06, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics,…
HUTCHMED to Announce 2025 Half-Year Financial Results
July 03, 2025 04:30 ET | Source: HUTCHMED (China) Limited HONG KONG…
PolyPid to Host Conference Call and Webcast to Discuss D-PLEX SHIELD II Phase 3 Trial Topline Results on Monday, June 9, 2025
June 06, 2025 16:05 ET | Source: PolyPid Ltd. PETACH TIKVA, Israel, June…